PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 30 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,077 | -42.6% | 116,914 | -30.8% | 0.00% | – |
| Q2 2023 | $338,000 | -50.9% | 169,000 | -48.4% | 0.00% | – |
| Q1 2023 | $688,271 | +160.6% | 327,748 | +70.0% | 0.00% | – |
| Q4 2022 | $264,146 | +146.9% | 192,807 | +88.2% | 0.00% | – |
| Q3 2022 | $107,000 | -10.8% | 102,457 | -7.0% | 0.00% | – |
| Q2 2022 | $120,000 | +140.0% | 110,115 | +136.3% | 0.00% | – |
| Q1 2022 | $50,000 | -23.1% | 46,600 | -40.1% | 0.00% | – |
| Q4 2021 | $65,000 | -75.9% | 77,815 | -61.6% | 0.00% | – |
| Q3 2021 | $270,000 | -61.5% | 202,545 | -44.9% | 0.00% | – |
| Q2 2021 | $701,000 | +91.5% | 367,386 | +347.1% | 0.00% | – |
| Q1 2021 | $366,000 | +320.7% | 82,172 | +241.0% | 0.00% | – |
| Q4 2020 | $87,000 | +4.8% | 24,100 | +12.1% | 0.00% | – |
| Q3 2020 | $83,000 | -39.0% | 21,500 | -39.9% | 0.00% | – |
| Q2 2020 | $136,000 | – | 35,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spire Wealth Management | 148,800 | $158,000 | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 244,332 | $257,000 | 0.00% |
| Phoenix Holdings Ltd. | 244,113 | $259,000 | 0.00% |
| IHT Wealth Management, LLC | 24,000 | $25,000 | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
| Virtu Financial LLC | 15,199 | $16,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 41,574 | $44,000 | 0.00% |
| Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,790 | $31,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,153 | $5,000 | 0.00% |